Granules India Ltd., incorporated in the year 1991, is a Mid Cap company (having a market cap of Rs 13,499.94 Crore) operating in Pharmaceuticals sector. Granules India Ltd. key Products/Revenue ...

algaes or grasses that have been processed and distilled into a powdered form. They often include 25 to 40 or more ingredients, and natural sugar substitutes may be added to improve the flavor.

Granules India has received USFDA approval to market a generic medication for major depressive disorder, Bupropion Hydrochloride extended-release tablets USP (SR), expanding its presence in the US ...

The Quarterly Results page of Granules India Ltd. presents the key result items, its comparison with the sector peers and its previous 5 Quarterly Results.